LS Biopath
Saratoga, US · Delaware corporation
Founders & leadership
JP
Jim PfeifferNamed on SEC filing
MS
Moshe SarfatyNamed on SEC filing
RK
Rusmin KudinarNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.9M disclosed across 1 round · 2021
▶$6.9MraisedJul 2021 · 51 investors · BiotechnologyRule 506(b)
▶$6.9MraisedJul 2021 · 51 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim PfeifferDirector
- Moshe SarfatyExecutive Officer, Director
- Rusmin KudinarDirector
- Offering amount
- $8M
- Amount sold
- $6.9M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has LS Biopath raised?
- LS Biopath has disclosed $6.9M raised across 1 round.
- Where is LS Biopath headquartered?
- LS Biopath is headquartered in Saratoga, US.